120 related articles for article (PubMed ID: 1336062)
1. Lidocaine block of human heart sodium channels expressed in Xenopus oocytes.
Chahine M; Chen LQ; Barchi RL; Kallen RG; Horn R
J Mol Cell Cardiol; 1992 Nov; 24(11):1231-6. PubMed ID: 1336062
[TBL] [Abstract][Full Text] [Related]
2. Intrinsic lidocaine affinity for Na channels expressed in Xenopus oocytes depends on alpha (hH1 vs. rSkM1) and beta 1 subunits.
Makielski JC; Limberis J; Fan Z; Kyle JW
Cardiovasc Res; 1999 May; 42(2):503-9. PubMed ID: 10533585
[TBL] [Abstract][Full Text] [Related]
3. Cardiac sodium channels (hH1) are intrinsically more sensitive to block by lidocaine than are skeletal muscle (mu 1) channels.
Nuss HB; Tomaselli GF; Marbán E
J Gen Physiol; 1995 Dec; 106(6):1193-209. PubMed ID: 8786356
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological modulation of human cardiac Na+ channels.
Krafte DS; Davison K; Dugrenier N; Estep K; Josef K; Barchi RL; Kallen RG; Silver PJ; Ezrin AM
Eur J Pharmacol; 1994 Feb; 266(3):245-54. PubMed ID: 8174607
[TBL] [Abstract][Full Text] [Related]
5. Functional consequences of lidocaine binding to slow-inactivated sodium channels.
Balser JR; Nuss HB; Romashko DN; Marban E; Tomaselli GF
J Gen Physiol; 1996 May; 107(5):643-58. PubMed ID: 8740377
[TBL] [Abstract][Full Text] [Related]
6. Isoform-specific lidocaine block of sodium channels explained by differences in gating.
Nuss HB; Kambouris NG; Marbán E; Tomaselli GF; Balser JR
Biophys J; 2000 Jan; 78(1):200-10. PubMed ID: 10620286
[TBL] [Abstract][Full Text] [Related]
7. Expression of cardiac Na channels with appropriate physiological and pharmacological properties in Xenopus oocytes.
Krafte DS; Volberg WA; Dillon K; Ezrin AM
Proc Natl Acad Sci U S A; 1991 May; 88(10):4071-4. PubMed ID: 1709733
[TBL] [Abstract][Full Text] [Related]
8. Blocking effect of methylflavonolamine on human Na(V)1.5 channels expressed in Xenopus laevis oocytes and on sodium currents in rabbit ventricular myocytes.
Fan XR; Ma JH; Zhang PH; Xing JL
Acta Pharmacol Sin; 2010 Mar; 31(3):297-306. PubMed ID: 20173760
[TBL] [Abstract][Full Text] [Related]
9. Coexpression of beta 1 with cardiac sodium channel alpha subunits in oocytes decreases lidocaine block.
Makielski JC; Limberis JT; Chang SY; Fan Z; Kyle JW
Mol Pharmacol; 1996 Jan; 49(1):30-9. PubMed ID: 8569709
[TBL] [Abstract][Full Text] [Related]
10. Human cardiac sodium channels expressed in Xenopus oocytes.
Tomaselli GF; Feldman AM; Yellen G; Marban E
Am J Physiol; 1990 Mar; 258(3 Pt 2):H903-6. PubMed ID: 1690519
[TBL] [Abstract][Full Text] [Related]
11. Distinct local anesthetic affinities in Na+ channel subtypes.
Wang DW; Nie L; George AL; Bennett PB
Biophys J; 1996 Apr; 70(4):1700-8. PubMed ID: 8785328
[TBL] [Abstract][Full Text] [Related]
12. Common molecular determinants of flecainide and lidocaine block of heart Na+ channels: evidence from experiments with neutral and quaternary flecainide analogues.
Liu H; Atkins J; Kass RS
J Gen Physiol; 2003 Mar; 121(3):199-214. PubMed ID: 12601084
[TBL] [Abstract][Full Text] [Related]
13. Outward stabilization of the S4 segments in domains III and IV enhances lidocaine block of sodium channels.
Sheets MF; Hanck DA
J Physiol; 2007 Jul; 582(Pt 1):317-34. PubMed ID: 17510181
[TBL] [Abstract][Full Text] [Related]
14. Lidocaine block of neonatal Nav1.3 is differentially modulated by co-expression of beta1 and beta3 subunits.
Lenkowski PW; Shah BS; Dinn AE; Lee K; Patel MK
Eur J Pharmacol; 2003 Apr; 467(1-3):23-30. PubMed ID: 12706451
[TBL] [Abstract][Full Text] [Related]
15. Lidocaine alters activation gating of cardiac Na channels.
Hanck DA; Makielski JC; Sheets MF
Pflugers Arch; 2000 Apr; 439(6):814-21. PubMed ID: 10784357
[TBL] [Abstract][Full Text] [Related]
16. Local anesthetics as effectors of allosteric gating. Lidocaine effects on inactivation-deficient rat skeletal muscle Na channels.
Balser JR; Nuss HB; Orias DW; Johns DC; Marban E; Tomaselli GF; Lawrence JH
J Clin Invest; 1996 Dec; 98(12):2874-86. PubMed ID: 8981936
[TBL] [Abstract][Full Text] [Related]
17. Effects of bisaramil, a novel class I antiarrhythmic agent, on heart, skeletal muscle and brain Na+ channels.
Pugsley MK; Goldin AL
Eur J Pharmacol; 1998 Jan; 342(1):93-104. PubMed ID: 9544797
[TBL] [Abstract][Full Text] [Related]
18. Molecular determinants of drug access to the receptor site for antiarrhythmic drugs in the cardiac Na+ channel.
Qu Y; Rogers J; Tanada T; Scheuer T; Catterall WA
Proc Natl Acad Sci U S A; 1995 Dec; 92(25):11839-43. PubMed ID: 8524860
[TBL] [Abstract][Full Text] [Related]
19. Differential modulation of Nav1.7 and Nav1.8 peripheral nerve sodium channels by the local anesthetic lidocaine.
Chevrier P; Vijayaragavan K; Chahine M
Br J Pharmacol; 2004 Jun; 142(3):576-84. PubMed ID: 15148257
[TBL] [Abstract][Full Text] [Related]
20. Two human paramyotonia congenita mutations have opposite effects on lidocaine block of Na+ channels expressed in a mammalian cell line.
Fan Z; George AL; Kyle JW; Makielski JC
J Physiol; 1996 Oct; 496 ( Pt 1)(Pt 1):275-86. PubMed ID: 8910215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
